People are applying ‘butt cream' to replace this expensive beauty treatment — but experts warn it's dangerous
People are swapping Botox for hemorrhoid cream — and experts are begging them to stop.
TikTok's latest wave of unhinged beauty hacks comes with concern: dabbing hemorrhoid cream on under-eye bags to supposedly smooth and de-puff without ever stepping into a derm's office.
Advertisement
On the social media platform, women are claiming that Preparation H is a miracle fix for puffy eyes, saying that it supposedly tightens skin and mimics the effect of under-eye filler — an expensive non-surgical treatment used to reduce dark circles and hollowness by adding volume.
But dermatologists are popping the puff-reducing bubble.
New York City-based dermatologist Dr. Shereene Idriss — a board-certified expert in facial rejuvenation — has long warned against the hemorrhoid hack, especially since some creams contain phenylephrine, a vasoconstrictor and steroids.
Advertisement
Using a cream with phenylephrine 'plus the steroid around the eyes' can 'increase your risk of glaucoma,' Idriss warned in a TikTok video.
Steroid creams, she added, 'worsen the look of your wrinkles and the redness around your eyes' and give you a 'shrivelly' appearance.
Fellow New York City-based dermatologist Dr. Mark Strom agreed, advising those who are adamant about trying this bizarre trend to be 'especially careful not to choose a hemorrhoid cream with hydrocortisone in it, as that's a topical steroid that will thin out your skin with everyday, long-term, continuous use,' he said in a TikTok video
Advertisement
This is a dangerous trend that can 'increase your risk of glaucoma' and 'worsen the look of your wrinkles and the redness around your eyes,' according to experts.
KMPZZZ – stock.adobe.com
If there is any butt product on the market that can be safely used under the eye, according to Idriss it's 'diaper rash cream/butt paste.'
Unlike hemorrhoid creams, these are 'soothing and calming because [they have] zinc oxide.'
Advertisement
Her favorite? Triple Paste, which contains 12% zinc oxide, cornstarch and oat kernel extract.
Supposedly, Triple Paste can be used all over the skin because 'The cornstarch is beneficial for your pores if you are dry, but get a bit oily or acne-prone in your T-zone,' she told Yahoo Life.
'Oat kernel extract is also anti-inflammatory and a natural humectant to help attract moisture to your skin,' she continued.
When it comes to trying any hack on social media, always proceed with caution and speak with a doctor first.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
3 hours ago
- Medscape
Experimental MS Drug Nearly Eliminates Disease Activity
PHOENIX — Frexalimab, a second-generation anti-CD40 ligand monoclonal antibody provides extended tight control of multiple sclerosis (MS) whether measured by relapse or brain imaging at 2-year follow-up, results of an open-label extension (OLE) of a phase 2 trial showed. 'At week 96, there was almost complete suppression of new gadolinium-enhancing lesions with very similar pattern seen with new or enhancing T2 lesions,' said study investigator Stephen Krieger, MD, professor of neurology, Icahn School of Medicine at Mount Sinai, New York City. Two phase 3 international studies with this drug are already enrolling. 'Part of the interest in frexalimab and anti-CD40 therapies is the idea that one can modulate both B- and T-cell activity without cell depletion,' explained Krieger, who presented the long-term open-label data on May 29 at the Consortium of Multiple Sclerosis Centers (CMSC) 2025 Annual Meeting. Near Complete Disease Suppression The latest data suggest frexalimab is fulfilling its promise. Over follow-up to date, there has been nearly complete suppression of gadolinium-enhancing (Gd+) lesions on MRI among those taking the dose now being tested in the phase 3 trials. At 2 years, with an annualized relapse rate of 0.08%, 92% of patients were relapse-free. The randomized portion of this phase 2 trial attracted attention when it was published a year ago in The New England Journal of Medicine , but the 2-year results showed that the efficacy and safety observed at 12 weeks persist. In the controlled trial, 129 patients with relapsing MS were randomized to 300-mg, 400-mg, 600-mg, or 1200-mg frexalimab or matching placebos. Suppression of Gd+ lesions was the primary endpoint. At 12 weeks, the adjusted mean of new Gd+ lesions was 1.4 in the combined placebo groups but 0.3 in the 300-mg frexalimab group and 0.2 in the 1200-mg group. Of those who participated in the randomized portion of the phase 2 trial, 97% continued into the long-term OLE. The OLE consisted of two arms: 1200-mg frexalimab administered intravenously every 4 weeks or 300-mg frexalimab administered subcutaneously every 2 weeks. At the end of 2 years, when 82% of those enrolled in the OLE were still on medication, the adjusted mean for new T1-weighted Gd+ lesions ranged from 0.1 to 0.3 across study arms whether on continuous frexalimab or switched from placebo to frexalimab. For those who were initiated on the 1200-mg dose in the controlled portion of the trial and remained on this dose for the OLE, the mean was 0.1. For the secondary endpoint of new or enlarging T2 lesions, the suppression at 2 years was almost the same. Again, the adjusted mean for new lesions across all arms ranged from 0.1 to 0.3. For those receiving the 1200-mg dose, the mean was 0.2. Mean T2 lesion volume increased in the placebo arm but not in the treatment arms during the randomized phase. After entering the OLE, T2 lesion volume fell in placebo patients now on active therapy. In the 1200-mg arm, the fall in lesion volume during the randomized phase continued into the first 24 weeks of the OLE. After 24 weeks, the lesion volume remained suppressed with no return toward baseline. Those initiated on placebo never caught up after switching to frexalimab. Relapse Rare — 2% at 96 Weeks On the 1200-mg dose of frexalimab, only 8% had any relapse recorded over the extended follow-up. In half, there was a single relapse. Only 2% had three or more relapses. While the Expanded Disability Status Scale score declined slightly among placebo patients once started on active therapy, there was no change from baseline through 96 weeks in patients started on any active therapy. As postulated by earlier preclinical and clinical studies, frexalimab had no effect on lymphocyte counts over time. Over the 96-week follow-up, levels of immunoglobulins remained unchanged, according to Krieger who showed graphs with straight lines for these values over the course of the OLE. Due to the potential of suppressing activation of both T and B cells over time, anti-CD40 therapies have long been considered a promising mechanism for control of MS. However, clinical development of first-generation drugs was abandoned because of an association with thromboembolism. 'Frexalimab has been engineered to avoid these events through a change in the Fc receptors with reduces downstream inflammatory events,' said Krieger. The long-term data support this premise. Over 2 years, there was one pulmonary embolism, but this exception was observed in a patient with a viral illness and a genetic predisposition for an inflammatory response, according to Krieger. When surveying other adverse events, 'nothing jumps out' in the OLE relative to the randomized phase. One potential exception is a rise in liver function tests observed in two (4%) patients on the 1200-mg dose. Only one of these patients discontinued therapy, and the levels returned to normal over time in both. The effects of the anti-CD40 mechanism on both the adaptive and innate immune systems suggest frexalimab might offer efficacy for both progressive and relapsing MS. In the ongoing phase 3 program, one of the trials (FREXALT) is enrolling patients with relapsing MS. The other (FREVIVA) is enrolling patients with progressive disease. Fulfilling its Promise Commenting on the results, Amit Bar-Or, MD, Chief of the Multiple Sclerosis Division, the Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, described frexalimab as 'a very interesting drug.' He agreed that the CD40 ligand is a promising target in MS but cautioned that these phase 2 data cannot answer the most interesting questions. This includes the more robust evidence of safety and efficacy from phase 3 trials, but it remains unclear whether the benefits extend beyond controlling relapsing disease. 'I think there is particular interest in whether it will also show extended benefit in progressive MS, and this will be a major focus of interest from the next set of studies,' Bar-Or said.
Time Business News
3 hours ago
- Time Business News
Fast Relief from Sleepless Nights – Sleeping Pills with Next Day UK Delivery
Your entire life will suffer negative effects when you lack sleep because it destroys your mood and energy as well as your concentration and your ability to function during daylight hours. Among the many people experiencing sleep difficulties, you probably search for an effective and quick solution for better rest. The wide range of sleeping pills in the UK is now more available through trusted online pharmacies that provide next-day UK delivery. The waiting time for relief is now reduced because you receive it without delay. People throughout the UK benefit from buying sleeping pills online for next-day delivery which revolutionizes their management approach to insomnia and sleep-related disturbances. The purpose ofSleeping Pills UK is to assist patients in quickest sleep onset and optimal sleep duration resulting in improved quality rest. Multiple types of sleeping pills exist in the market and patients can obtain their medicines through both prescribed drug channels and no prescribed channels. Acute insomnia together with short-term sleep problems requires medical prescription of both Zopiclone and Zolpidem medications. These medications now constitute some of the most effective sleeping pills present in the UK market. The market provides over-the-counter products for individuals facing periodic sleep issues. The market offers two main types of medications including antihistamine and herb-based formulas suitable for those who prefer gentler treatments. When you do not sleep well, time becomes important. Waiting for several days to get help can worsen symptoms such as anxiety, poor concentration and low productivity. This is the day after the delivery of the UK. With this service you can buy UK Sleeping Pills and deliver them to the door within 24 hours. The facility and speed of buying online sleeping pills in the UK can make a big difference for someone suffering from back-to-back sleepless nights. Getting rapid relief means avoiding long -term mental and physical consequences of ongoing shortage of sleep. Safety is needed when choosing to Buy Sleeping Pills UK. Always look for licensed UK-based online pharmacies registered with medicines and health product regulation agency (MHRA). These sites will usually need to fill out a medical questionnaire, which will be reviewed by a qualified health care provider. Avoid websites that provide sleeping pills without any kind of consultation or prescription. These sites can sell false or irregular medicines that may be dangerous to your health. When you use a valid supplier, your consultation, approval and distribution process is handled by professionals and safe. If you are looking for the best sleeping pills available in the UK, Zopiclone and Zolpidem are two of the most prescribed drugs for insomnia. Zopiclone is often available at 7.5 mg tablet and is known to help individuals quickly sleep and sleep at night. Zolpidem, a more widespread drug, has a similar effect and is often preferred for its little life, which reduces the possibility of growing the next day. In addition to these recipe options, natural sleep aids such as melatonin-based supplements, valerian root or antihistamine can also be purchased for Miller symptoms. The opportunity to buy online sleeping pills in the UK provides many benefits. First of all, you save time by avoiding commercial appointments and pharmacy visits. Second, online pharmacies often offer better prices and proper packaging. Third, the next day's delivery lets you address immediate sleep problems without delay. You can also review different product options, customers can read reviews and get medical guidance without leaving home. This availability has purchased the Go-to method for many people who relieve insomnia and other sleep problems in the UK. Click Here to Buy Sleeping Pills Online at UK Sleep Care. It is important to consider the cause of your sleeplessness before you start taking some sleeping pills the UK. Stress, diet, irregular sleep routine and mental health disorders can all play a role in troubled sleep. While the drug can provide immediate relief, long -term solutions often include lifestyle changes. It is recommended to use sleeping pills for short -term support while improving sleep hygiene. This includes maintaining a steady sleep, reducing screen time before bedtime, limiting caffeine intake in the evening and creating a cool sleep environment. Sleep pills can be very effective for those who need quick relief from sleep evenings. However, they are not for everyone. People with a history of drug addiction, breathing problems or some chronic conditions should consult a doctor before using them. Fortunately, when you buy the UK from a well-known online pharmacy, you will get the right medical guidance to ensure that the drug is right for you. If you have tried to change natural means and lifestyle without success, a small course of prescribed British sleep pills can help reset the sleep cycle and improve your overall health. Sleep is important for your physical and mental welfare. Lack of sleep can lead to chronic fatigue, weak immune function, irritability and even depression. This is why quick access to the best sleeping pills with the next day's delivery is more than a luxury – this is a requirement for many. Being able to buy online sleeping pills in the UK gives you control of your sleep health supported health. Whether you work with jet intervals, stress or ongoing insomnia, access to effective drug the next day means that you no longer need to suffer through endless sleep evenings. For people struggling with poor sleep, quick access is important for effective treatment. Thanks to the Internet, it is much easier to Buy Sleeping Pills UK, and has been distributed the following day. Whether you are looking for treatment or prescription solutions, reliable online pharmacies in the UK provide safe, practical and professional service. Sleep should not be a luxury. If you are ready to control your nights and restore your days, consider the facility to buy online sleeping pills in the UK with delivery in the UK the following day. TIME BUSINESS NEWS
Yahoo
3 hours ago
- Yahoo
BayCare and Northwestern Medicine partner to improve healthcare services in Florida
US-based health systems BayCare and Northwestern Medicine have partnered to broaden access to medical treatment and improve clinical research, training and education for physicians in West Central Florida. The initiative is expected to increase BayCare's capacity to attract, retain and train healthcare professionals to meet increasing patient demands in the region. It is part of BayCare's growth strategy for the Florida region, particularly the Tampa Bay area. BayCare president and CEO Stephanie Conners said: 'This isn't the beginning, it's the next step in a journey we've been focused on for years. 'West Central Florida deserves more access to academic medicine and by entering into a strategic collaboration with Northwestern Medicine, we will accelerate our trajectory as an academic health system.' Both organisations have signed a definitive agreement and have begun the first phase of the partnership, focusing on educational and professional development for clinicians and clinical research advancement. The partnership was announced on 5 June at Tampa Bay Park, where BayCare recently acquired three office buildings. Northwestern Memorial HealthCare president and CEO Howard Chrisman said: 'We are focused on collaborating with like-minded organisations that are driven by providing patients with greater access to world-class compassionate care, closer to where they live and work. 'By collaborating with BayCare, we have the opportunity to train and educate the next generation of medical professionals and transform the clinical offerings to patients in West Central Florida.' Northwestern Medicine provides care across 11 hospitals and more than 200 ambulatory and diagnostic sites in Chicago, Illinois, with Northwestern Memorial Hospital as its primary facility. BayCare operates 16 hospitals and numerous other facilities. The partnership with Northwestern Medicine will not affect its ownership, leadership or board composition. Last year, BayCare partnered with Cadence to launch a remote patient monitoring and responsive virtual care programme. "BayCare and Northwestern Medicine partner to improve healthcare services in Florida" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
